Stay Alert for Patients on Hep C Meds Reporting High or Low Blood Sugars

Health Canada is warning about possible blood sugar changes in patients who take certain hep C meds.

The concern is with newer hepatitis meds called "direct-acting antivirals"...such as Epclusa, Maviret, and Zepatier.

There are reports of patients having low or high blood glucose levels or developing diabetes while taking these meds.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote